JCM
DGX icon

Julex Capital Management’s Quest Diagnostics DGX Stock Holding History

Julex Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13
Closed -$1K – 184
2019
Q2 		$1K Sell
13
-1
-7% -$96 ﹤0.01% 101
2019
Q1 		$1.26K Hold
14
– – ﹤0.01% 127
2018
Q4 		$1K Buy
+14
New +$1.31K ﹤0.01% 91

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Julex Capital Management's DGX Position: Q3 2019 in Review

Julex Capital Management sold out of Quest Diagnostics (DGX) in Q3 2019, closing a stake of 13 shares — an estimated $1K sold.

Julex Capital Management first reported a position in DGX in Q4 2018 and held it in 3 quarters. The position peaked at $1.26K in Q1 2019. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Julex Capital Management reported no remaining Quest Diagnostics position as of Q3 2019 after selling out during the quarter.
  • Julex Capital Management sold 13 Quest Diagnostics shares in Q3 2019, an estimated $1K.
  • Julex Capital Management first reported a position in Quest Diagnostics in Q4 2018 and held it in 3 quarters.
  • Julex Capital Management's Quest Diagnostics position peaked at $1.26K in Q1 2019.
  • 677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Julex Capital Management's 13F filing for Q3 2019, filed 18 Oct 2019.